Tune Therapeutics

Tune Therapeutics, a biotechnology company headquartered in Durham, North Carolina, employs 89 individuals. Founded in the United States, Tune Therapeutics specializes in developing innovative epigenomic therapies. Tune Therapeutics focuses on pioneering epi-therapeutic medicines using its proprietary TEMPO platform. TEMPO allows for precise control over gene expression, effectively "tuning" gene activity toward healthy levels without altering DNA permanently. This unique approach targets multiple genes simultaneously, offering the potential to reverse pathways associated with cancer, genetic diseases, and aging. Their genetic tuning technology expands the possibilities of genetic medicine, addressing a broader spectrum of diseases, including complex and chronic conditions lacking curative treatments. For inquiries, interested parties can visit Tune Therapeutics' website at tuntx.com.